NTRA Natera, Inc. - Common Stock
$325,35
السعر · أغسطس 24, 2026
البيانات الأساسية اعتبارًا من أغسطس 7, 2026
نطاق 52 أسبوعًا
$157–$334
95% of range
تقييم المحللين
BUY
30 analysts
السعر المستهدف
$337
+4% upside
P/E (TTM)
-214.0
ROE
-14.1%
هامش صافي الربح
-9.0%
حول Natera, Inc. - Common Stock نظرة عامة على الشركة من ويكيبيديا
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
اقرأ المزيد
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, California and Austin, Texas.
History
Natera (previously Gene Security Network) was founded by Matthew Rabinowitz and Jonathan Sheena in 2004. Natera launched its first product, the Spectrum preimplantation genetic test, in 2009.
In 2010, the company introduced the Anora miscarriage (POC) test. Natera's advanced carrier screening test, Horizon, launched in 2012. The following year, 2013, Natera launched the Panorama non-invasive prenatal test (NIPT).
In July 2015, Natera conducted an initial public offering of common stock at a price of $18.00 per share. The shares trade on the Nasdaq Global Select Market under the symbol "NTRA."
In 2017, Natera launched the Vistara single-gene NIPT. That same year, Natera introduced the Signatera molecular residual disease (MRD) test for research use only. The Signatera CLIA test was introduced for clinical use in 2019.
In 2018 Natera paid a $11 million fine to the department over allegations of improper billing and sales of Panorama to federal Healthcare services between the years of 2013 to 2016.
Natera launched the Prospera dd-cfDNA transplant assessment test in 2019, and the Renasight kidney gene panel and the Empower hereditary cancer test in 2020.
As of May 2021, Natera has performed over 3 million cell-free DNA tests. Natera's technology has also been written about in over 200 peer-reviewed journals and publications, including Nature, Science Magazine, and the Journal of Clinical Oncology.
Products and services
Women's health
The Panorama NIPT is the only single-nucleotide polymorphism (SNP)-based NIPT. The test analyzes fetal DNA found in the mother's blood to reveal a baby's risk for genetic disorders such as Down syndrome (trisomy 21) and Edwards syndrome (trisomy 18) as early as nine weeks. Panorama also tests for unique microdeletions and is the only test that can detect zygosity and fetal sex in twins.
Natera also offers Horizon, a carrier-screening test that uses next-generation sequencing to provide carrier status for up to 274 genetic conditions. Additionally, Natera offers the Anora products of conception (POC) miscarriage test, the Spectrum preimplantation genetic screening and diagnosis test, and the Vistara single-gene prenatal screening test. In 2020, Natera launched Empower, a hereditary cancer test that screens for up to 53 genes associated with increased risk for common hereditary cancers.
Oncology
Signatera is the first circulating tumor DNA (ctDNA) assay built for molecular residual disease (MRD) detection and cancer recurrence monitoring. In 2020, Signatera received the CE Mark, as well as final Medicare coverage in stage II-III colorectal cancer and draft coverage in immunotherapy response monitoring. Signatera has been clinically validated to detect colorectal cancer recurrence up to 16.5 months in advance of radiologic imaging and early-stage breast cancer up to two years earlier than imaging.
Organ health
The Prospera test is the first assay with high sensitivity to both T-cell-mediated and antibody-mediated rejection. In December 2019, the test received final Medicare coverage. In 2020, Natera launched Renasight, a test to determine if there is a genetic cause for an individual's kidney disease and if there may be other at-risk relatives.
Constellation
Natera offers a cloud-based bioinformatics platform called Constellation, allowing laboratories to access and use Natera's technology in their own facilities. Constellation is currently only available outside of the United States.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
NTRA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
السعر
$325.35
القيمة السوقية
$45.45B
P/E (TTM)
-214.0
ربح السهم (آخر 12 شهرًا)
$-1.52
الإيرادات (آخر 12 شهرًا)
$2.31B
عائد التوزيعات
—
ROE
-14.1%
D/E الدين/حقوق الملكية
0.0
نطاق 52 أسبوعًا
$157 – $334
NTRA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
Configure
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
الإيرادات وصافي الدخل
$2.31B
2016-12-31
→
2025-12-31
ربح السهم
$-1.52
2016-12-31
→
2025-12-31
التدفق النقدي الحر
$109M
2016-12-31
→
2025-12-31
الهوامش
-9.0%
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
المقياس
اتجاه 5 سنوات
NTRA
متوسط الأقران
P/E (TTM)
-214.0
17.7
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
19.7
6.8
P/B (السعر / القيمة الدفترية)
26.5
6.4
Price / FCF (السعر / التدفق النقدي الحر)
416.5
—
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
المقياس
اتجاه 5 سنوات
NTRA
متوسط الأقران
Operating Margin (هامش التشغيل)
-13.4%
—
Net Profit Margin (هامش صافي الربح)
-9.0%
20.3%
ROA (العائد على الأصول)
-10.3%
11.4%
ROE
-14.1%
16.8%
ROIC
-13.4%
—
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
المقياس
اتجاه 5 سنوات
NTRA
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
0.0
—
Current Ratio (النسبة الحالية)
3.4
3.4
Quick Ratio (النسبة السريعة)
0.7
—
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
المقياس
اتجاه 5 سنوات
NTRA
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
35.9%
—
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
41.1%
—
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
42.6%
—
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
المقياس
اتجاه 5 سنوات
NTRA
متوسط الأقران
NTRA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
شراء
30 محللين
- شراء قوي 12 40,0%
- شراء 14 46,7%
- احتفاظ 4 13,3%
- بيع 0 0,0%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
21 محللين · 2026-08-24
الوسيط
$348.00
المتوسط
$336.74
الآن
$325.35
منخفض
$280.00
مرتفع
$375.00
السعر المستهدف الوسيط
$348.00
+7,0%
السعر المستهدف المتوسط
$336.74
+3,5%
سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
متوسط المفاجأة
0.11%
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $-0.47 | $-0.50 | 0.03% |
| 31 مارس، 2026 | $-0.60 | $-0.55 | -0.05% |
| 31 ديسمبر، 2025 | $0.36 | $-0.52 | 0.88% |
| 30 سبتمبر، 2025 | $-0.64 | $-0.38 | -0.26% |
| 30 يونيو، 2025 | $-0.74 | $-0.63 | -0.11% |
| 31 مارس، 2025 | $-0.50 | $-0.65 | 0.15% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| MRNA | $11.62B | -4.1 | -39.9% | -145.2% | -31.3% | — |
| RVMD | — | — | — | — | — | — |
| BIIB | $25.84B | 20.0 | 2.2% | 13.1% | 7.2% | — |
| ALNY | $52.64B | 170.7 | 65.2% | 8.5% | 60.4% | — |
| INSM | $37.29B | -27.1 | 66.7% | -210.5% | -128.4% | — |
| INCY | $19.60B | 15.4 | 21.2% | 25.0% | 27.6% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | $159M | |
| Cost of Revenue | · | · | · | · | · | · | · | $158M | $136M | $134M | $113M | $78M | |
| R&D Expense | $624M | $404M | $321M | $316M | $264M | $100M | $51M | $51M | $50M | $42M | $28M | $17M | |
| SG&A Expense | $1.18B | $841M | $618M | $589M | $511M | $304M | $206M | $155M | $155M | $136M | $110M | $63M | |
| Operating Expenses | $2.62B | $1.92B | $1.53B | $1.36B | $1.09B | $607M | $419M | $372M | $345M | $314M | $250M | $159M | |
| Operating Income | $-310M | $-222M | $-446M | $-541M | $-468M | $-216M | $-116M | $-115M | $-135M | $-101M | $-60M | $665.0K | |
| Interest Expense | $4M | $11M | $13M | $9M | $8M | $15M | $11M | $10M | $4M | $533.0K | $4M | $4M | |
| Other Non-op | · | · | · | · | · | · | · | · | · | · | $-8M | $-2M | |
| Pretax Income | $-268M | $-190M | $-435M | $-547M | $-471M | $-230M | $-123M | $-128M | $-137M | $-100M | $-70M | $-5M | |
| Income Tax | $-60M | $695.0K | $271.0K | $978.0K | $618.0K | $98.0K | $2M | $321.0K | $454.0K | $142.0K | · | $15.0K | |
| Net Income | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | $-5M | |
| EPS (Basic) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.58 | $-1.95 | $-2.68 | · | |
| EPS (Diluted) | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 | $-2.84 | $-1.79 | $-2.22 | $-2.59 | $-1.95 | $-2.68 | · | |
| Shares (Basic) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,312,000 | 51,576,000 | 26,204,000 | · | |
| Shares (Diluted) | 136,721,000 | 124,718,000 | 114,997,000 | 98,408,000 | 90,558,000 | 81,011,000 | 69,555,000 | 57,848,000 | 53,604,000 | 51,576,000 | 26,204,000 | · | |
| EBITDA | $-268M | $-191M | $-422M | $-524M | $-457M | $-208M | $-109M | $-107M | $-127M | $-90M | $-54M | · |
الميزانية العمومية 28
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $466M | $84M | $49M | $62M | $46M | $13M | $15M | $29M | $87M | |
| Short-term Investments | · | $23M | $237M | $432M | $830M | $689M | $379M | $107M | $106M | $131M | $202M | · | |
| Receivables | $297M | $314M | $278M | $244M | $122M | $79M | $53M | $62M | $44M | $13M | $6M | $6M | |
| Inventory | $68M | $45M | $41M | $35M | $27M | $20M | $12M | $14M | $9M | $6M | $8M | $12M | |
| Prepaid Expense | $56M | $49M | $61M | $34M | $30M | $27M | $16M | $6M | $9M | $7M | $5M | $1M | |
| Current Assets | $1.50B | $1.38B | $1.26B | $1.21B | $1.09B | $863M | $523M | $241M | $181M | $174M | $251M | $106M | |
| PP&E (Net) | $241M | $162M | $111M | $92M | $66M | $33M | $23M | $24M | $30M | $32M | $13M | $15M | |
| PP&E (Gross) | $352M | $240M | $168M | $128M | $85M | $83M | $65M | $59M | $57M | $52M | $26M | $24M | |
| Accum. Depreciation | $111M | $78M | $56M | $36M | $19M | $50M | $42M | $34M | $27M | $19M | $14M | $10M | |
| Goodwill | $141M | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $374M | $11M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $37M | $26M | $15M | $18M | $19M | $15M | $12M | $3M | $4M | $4M | $1M | $2M | |
| Total Assets | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Accounts Payable | $33M | $35M | $15M | $31M | $27M | $8M | $9M | $15M | $9M | $11M | $7M | $9M | |
| Accrued Liabilities | · | · | · | · | · | $60M | $49M | $32M | $33M | $20M | $19M | $10M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Current Liabilities | $441M | $344M | $307M | $310M | $219M | $199M | $180M | $114M | $106M | $96M | $80M | $30M | |
| Capital Leases | $118M | $97M | $67M | $77M | $61M | $21M | $26M | · | · | · | · | · | |
| Other Non-current Liabilities | $12M | $8M | · | · | $1M | $320.0K | $310.0K | · | $1M | · | · | · | |
| Total Liabilities | $686M | $465M | $676M | $689M | $583M | $446M | $304M | $236M | $189M | $104M | $80M | $54M | |
| Long-term Debt | · | · | $283M | $282M | $280M | · | · | · | · | · | · | · | |
| Total Debt | $80M | $80M | $80M | $80M | $50M | $50M | $50M | $50M | $50M | $50M | $42M | · | |
| Common Stock | $14.0K | $12.0K | $11.0K | $11.0K | $10.0K | $9.0K | $8.0K | $7.0K | $6.0K | $5.0K | $5.0K | $1.0K | |
| Retained Earnings | $-2.78B | $-2.57B | $-2.38B | $-1.94B | $-1.39B | $-929M | $-699M | $-575M | $-446M | $-346M | $-250M | $-180M | |
| AOCI | $-258.0K | $-344.0K | $-3M | $-16M | $-2M | $4M | $919.0K | $-552.0K | $-766.0K | $-725.0K | $-1M | · | |
| Stockholders' Equity | $1.71B | $1.20B | $765M | $706M | $653M | $486M | $279M | $32M | $25M | $144M | $226M | $-171M | |
| Liabilities + Equity | $2.40B | $1.66B | $1.44B | $1.39B | $1.24B | $932M | $583M | $268M | $215M | $211M | $265M | $124M | |
| Shares Outstanding | 139,693,000 | 132,646,000 | 119,581,000 | 111,255,000 | 95,140,000 | 86,223,000 | 78,005,000 | 62,083,000 | 54,040,000 | 52,665,000 | 50,346,000 | 6,879,000 |
التدفق النقدي 15
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $42M | $31M | $24M | $17M | $11M | $9M | $8M | $8M | $7M | $6M | $6M | $5M | |
| Stock-based Comp | $354M | $274M | $192M | $152M | $115M | $50M | $29M | $14M | $11M | $11M | $7M | $5M | |
| Amort. of Intangibles | $4M | $1M | $0 | · | · | · | $1M | $1M | $1M | $600.0K | $200.0K | $0 | |
| Restructuring | · | · | · | · | $400.0K | $400.0K | · | · | · | · | · | · | |
| Other Non-cash | $27M | $21M | $-28M | $-53M | $10M | $-12M | $25M | $36M | $21M | $5M | $20M | · | |
| Operating Cash Flow | $215M | $136M | $-247M | $-432M | $-335M | $-183M | $-63M | $-71M | $-98M | $-74M | $-38M | $10M | |
| CapEx | $106M | $66M | $39M | $48M | $41M | $20M | $5M | $4M | $10M | $23M | $8M | $10M | |
| Investing Cash Flow | $-132M | $138M | $168M | $330M | $-205M | $-331M | $-266M | $-5M | $14M | $47M | $-211M | · | |
| Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Net Debt Issued | · | · | · | · | · | · | · | · | $75M | · | · | · | |
| Financing Cash Flow | $47M | $30M | $254M | $483M | $576M | $501M | $341M | $114M | $80M | $13M | $190M | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $-3M | $-14M | $-58M | · | |
| Taxes Paid | $499.0K | $1M | $295.0K | $549.0K | $283.0K | $67.0K | $2M | $332.0K | $177.0K | · | · | · | |
| Free Cash Flow | $109M | $69M | $-286M | $-479M | $-376M | $-202M | $-68M | $-74M | $-107M | $-97M | $-46M | · | |
| Levered FCF | $106M | $59M | $-299M | $-489M | $-385M | $-217M | $-79M | $-85M | $-111M | $-98M | · | · |
الربحية 7
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% | -55.3% | -38.5% | -44.5% | -63.5% | -44.5% | -31.4% | · | |
| Net Margin | -9.0% | -11.2% | -40.2% | -66.8% | -75.4% | -58.8% | -41.3% | -49.7% | -64.6% | -44.1% | -36.9% | · | |
| Pretax Margin | -11.6% | -11.2% | -40.1% | -66.7% | -75.3% | -58.7% | -40.6% | -49.6% | -64.4% | -44.0% | · | · | |
| EBITDA Margin | -11.6% | -11.3% | -39.0% | -63.9% | -73.0% | -53.1% | -35.9% | -41.6% | -60.2% | -41.6% | -28.5% | · | |
| ROA | -10.3% | -12.3% | -30.7% | -41.6% | -43.5% | -30.3% | -29.3% | -53.1% | -70.0% | -40.2% | -36.1% | · | |
| ROE | -14.1% | -18.4% | -56.1% | -102.6% | -66.8% | -45.0% | -68.7% | -288.9% | -204.7% | -57.5% | -1046.5% | · | |
| ROIC | -13.4% | -17.5% | -52.8% | -69.0% | -66.6% | -40.4% | -35.9% | -139.6% | -338.4% | -61.9% | · | · |
السيولة والملاءة 4
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 | 4.3 | 2.9 | 2.1 | 1.4 | 1.8 | 3.1 | · | |
| Quick Ratio | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 | 4.1 | 2.7 | 1.9 | 1.2 | 1.7 | 2.9 | · | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 1.6 | -4.8 | 0.5 | 0.2 | · | |
| Interest Coverage | -76.2 | -20.8 | -35.3 | -58.1 | -56.4 | -14.3 | -10.9 | -10.9 | -31.8 | -181.0 | -17.1 | · |
الكفاءة 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.1 | 0.8 | 0.6 | 0.6 | 0.5 | 0.7 | 1.1 | 1.1 | 0.9 | 1.0 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 14.0 | 17.6 | 18.7 | 11.5 | · | |
| Receivables Turnover | 7.6 | 5.7 | 4.1 | 4.5 | 6.2 | 5.9 | 5.2 | 4.8 | 19.5 | 22.5 | 32.3 | · |
معدلات النمو 3
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 35.9% | 56.8% | 32.0% | 31.1% | 60.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 41.1% | 39.5% | 40.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 42.6% | · | · | · | · | · | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 14
| المقياس | اتجاه | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.31B | $1.70B | $1.08B | $820M | $625M | $391M | $302M | $258M | $210M | $213M | $190M | · | |
| Net Income TTM | $-208M | $-190M | $-435M | $-548M | $-472M | $-230M | $-125M | $-128M | $-138M | $-100M | $-70M | · | |
| Market Cap | $32.00B | $21.00B | $7.49B | $4.47B | $8.89B | $8.58B | $2.63B | $867M | $486M | $617M | $544M | · | |
| Enterprise Value | · | · | · | $3.65B | $8.02B | $7.89B | $2.24B | $763M | $417M | $520M | $355M | · | |
| P/E | -150.7 | -103.5 | -16.6 | -7.2 | -17.9 | -35.0 | -18.8 | -6.3 | -3.5 | -6.0 | -4.0 | · | |
| P/S | 13.9 | 12.4 | 6.9 | 5.4 | 14.2 | 21.9 | 8.7 | 3.4 | 2.3 | 2.9 | 2.9 | · | |
| P/B | 18.7 | 17.6 | 9.8 | 6.3 | 13.6 | 17.6 | 9.4 | 26.9 | -46.8 | 5.8 | 2.9 | · | |
| P / Tangible Book | 26.7 | 17.7 | 9.8 | 6.3 | 13.6 | 17.6 | · | · | · | · | · | · | |
| P / Cash Flow | 148.6 | 154.8 | -30.3 | -10.4 | -26.5 | -47.0 | -41.4 | -12.3 | -5.0 | -8.3 | -14.4 | · | |
| P / FCF | 293.3 | 303.3 | -26.2 | -9.3 | -23.6 | -42.5 | -38.4 | -11.6 | -4.6 | -6.4 | -11.9 | · | |
| EV / EBITDA | · | · | · | -7.0 | -17.6 | -38.0 | -20.6 | -7.1 | -3.3 | -5.8 | -6.5 | · | |
| EV / FCF | · | · | · | -7.6 | -21.3 | -39.1 | -32.7 | -10.2 | -3.9 | -5.4 | -7.8 | · | |
| EV / Revenue | · | · | · | 4.5 | 12.8 | 20.2 | 7.4 | 3.0 | 2.0 | 2.4 | 1.9 | · | |
| Earnings Yield | -0.66% | -0.97% | -6.0% | -13.9% | -5.6% | -2.9% | -5.3% | -15.9% | -28.8% | -16.7% | -24.8% | · |
قائمة الدخل 15
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $753M | $697M | $666M | $592M | $547M | $502M | $476M | $440M | $413M | $368M | $311M | $268M | $261M | $242M | $217M | $211M | |
| R&D Expense | $228M | $211M | $175M | $173M | $146M | $129M | $129M | $97M | $89M | $89M | $83M | $77M | $78M | $82M | $88M | $66M | |
| SG&A Expense | $327M | $328M | $291M | $309M | $311M | $267M | $235M | $214M | $198M | $194M | $161M | $155M | $153M | $150M | $144M | $148M | |
| Operating Expenses | $829M | $790M | $688M | $690M | $657M | $581M | $541M | $479M | $457M | $442M | $396M | $379M | $374M | $380M | $359M | $330M | |
| Operating Income | $-76M | $-94M | $-23M | $-98M | $-110M | $-79M | $-65M | $-39M | $-44M | $-74M | $-85M | $-111M | $-112M | $-138M | $-142M | $-119M | |
| Interest Expense | · | · | $990.0K | $1M | $1M | $1M | $1M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | |
| Other Non-op | $9M | $10M | · | · | $11M | $13M | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-67M | $-85M | $-13M | $-87M | $-101M | $-67M | $-55M | $-31M | $-37M | $-67M | $-78M | $-109M | $-111M | $-137M | $-142M | $-121M | |
| Income Tax | $-261.0K | $283.0K | $-61M | $207.0K | $275.0K | $173.0K | $-1M | $730.0K | $892.0K | $428.0K | $191.0K | $202.0K | $-282.0K | $160.0K | $421.0K | $185.0K | |
| Net Income | $-67M | $-85M | $47M | $-88M | $-101M | $-67M | $-54M | $-32M | $-37M | $-68M | $-78M | $-109M | $-111M | $-137M | $-143M | $-121M | |
| EPS (Basic) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| EPS (Diluted) | $-0.47 | $-0.60 | $0.36 | $-0.64 | $-0.74 | $-0.50 | $-0.41 | $-0.26 | $-0.30 | $-0.56 | $-0.63 | $-0.95 | $-0.97 | $-1.23 | $-1.37 | $-1.25 | |
| Shares (Basic) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| Shares (Diluted) | 143,279,000 | 141,502,000 | -271,604,000 | 137,187,000 | 136,388,000 | 134,750,000 | -242,724,000 | 123,775,000 | 122,853,000 | 120,814,000 | -225,631,000 | 115,171,000 | 113,690,000 | 111,767,000 | -190,801,000 | 97,052,000 | |
| EBITDA | $-76M | $-79M | · | $-98M | $-110M | $-70M | · | $-39M | $-44M | $-67M | · | $-111M | $-112M | $-133M | · | $-119M |
الميزانية العمومية 26
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $57M | |
| Short-term Investments | · | · | · | $1M | $16M | $18M | $23M | $29M | $90M | $69M | · | $268M | $355M | $409M | · | $464M | |
| Receivables | $422M | $418M | $297M | $286M | $309M | $318M | $314M | $307M | $336M | $289M | · | $255M | $260M | $247M | · | $236M | |
| Inventory | $80M | $71M | $68M | $65M | $54M | $50M | $45M | $49M | $41M | $43M | · | $42M | $43M | $41M | · | $40M | |
| Prepaid Expense | $65M | $76M | $56M | $54M | $52M | $56M | $49M | $45M | $38M | $47M | · | $33M | $27M | $30M | · | $32M | |
| Current Assets | $1.66B | $1.65B | $1.50B | $1.45B | $1.43B | $1.42B | $1.38B | $1.32B | $1.30B | $1.26B | · | $1.27B | $1.07B | $1.13B | · | $830M | |
| PP&E (Net) | $318M | $269M | $241M | $206M | $189M | $180M | $162M | $142M | $133M | $126M | · | $105M | $103M | $101M | · | $87M | |
| PP&E (Gross) | $451M | $390M | $352M | $307M | $281M | $267M | $240M | $213M | $198M | $185M | · | $155M | $148M | $141M | · | $119M | |
| Accum. Depreciation | $133M | $120M | $111M | $101M | $92M | $87M | $78M | $71M | $64M | $59M | · | $51M | $45M | $41M | · | $31M | |
| Goodwill | $141M | $141M | $141M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Intangibles | $360M | $367M | $374M | · | · | · | $11M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $50M | $51M | $37M | $71M | $41M | $41M | $26M | $38M | $29M | $26M | · | $16M | $18M | $19M | · | $18M | |
| Total Assets | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Accounts Payable | $75M | $62M | $33M | $46M | $37M | $39M | $35M | $28M | $33M | $26M | · | $21M | $21M | $36M | · | $34M | |
| Short-term Debt | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Current Liabilities | $553M | $558M | $441M | $442M | $385M | $366M | $344M | $301M | $315M | $306M | · | $290M | $277M | $291M | · | $267M | |
| Capital Leases | $143M | $145M | $118M | $104M | $103M | $103M | $97M | $99M | $61M | $64M | · | $68M | $71M | $74M | · | $78M | |
| Other Non-current Liabilities | $25M | $16M | $12M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $836M | $840M | $686M | $569M | $511M | $493M | $465M | $712M | $680M | $674M | · | $662M | $652M | $668M | · | $647M | |
| Total Debt | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $80M | $80M | $80M | · | $50M | |
| Common Stock | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $11.0K | $11.0K | $11.0K | · | $10.0K | |
| Retained Earnings | $-2.93B | $-2.86B | $-2.78B | $-2.82B | $-2.74B | $-2.63B | $-2.57B | $-2.51B | $-2.48B | $-2.45B | · | $-2.30B | $-2.19B | $-2.08B | · | $-1.80B | |
| AOCI | $-108.0K | $-202.0K | $-258.0K | $-187.0K | $-287.0K | $-197.0K | $-344.0K | $-765.0K | $-1M | $-2M | $-3M | $-5M | $-9M | $-12M | $-16M | $-20M | |
| Stockholders' Equity | $1.82B | $1.77B | $1.71B | $1.25B | $1.25B | $1.24B | $1.20B | $879M | $837M | $794M | $765M | $785M | $596M | $651M | $706M | $362M | |
| Liabilities + Equity | $2.66B | $2.61B | $2.40B | $1.82B | $1.76B | $1.73B | $1.66B | $1.59B | $1.52B | $1.47B | · | $1.45B | $1.25B | $1.32B | · | $1.01B | |
| Shares Outstanding | 143,612,000 | 142,734,000 | 139,693,000 | 137,533,000 | 136,757,000 | 135,932,000 | 132,646,000 | 124,137,000 | 123,365,000 | 122,234,000 | · | 118,990,000 | 114,051,000 | 113,359,000 | · | 97,300,000 |
التدفق النقدي 11
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $15M | $15M | $12M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $7M | $5M | $5M | $4M | $5M | |
| Stock-based Comp | $103M | $95M | $93M | $91M | $93M | $78M | $72M | $71M | $67M | $64M | $49M | $57M | $44M | $40M | $36M | $40M | |
| Amort. of Intangibles | $6M | $7M | · | · | $0 | $300.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $16M | · | · | · | $24M | · | · | · | $23M | · | · | · | $10M | · | · | |
| Operating Cash Flow | $55M | $40M | $74M | $59M | $38M | $44M | $53M | $52M | $4M | $27M | $-58M | $-30M | $-79M | $-81M | $-81M | $-102M | |
| CapEx | $63M | $22M | $36M | $22M | $26M | $22M | $18M | $16M | $12M | $20M | $10M | $9M | $9M | $11M | $12M | $12M | |
| Investing Cash Flow | $-63M | $-32M | $-72M | $-20M | $-24M | $-17M | $-11M | $43M | $-32M | $138M | $24M | $82M | $47M | $16M | $22M | $67M | |
| Financing Cash Flow | $12M | $4M | $32M | $2M | $13M | $544.0K | $11M | $2M | $11M | $6M | $7M | $236M | $9M | $2M | $468M | $1M | |
| Net Change in Cash | $4M | $12M | · | · | $26M | $28M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $18M | · | · | · | $23M | · | · | · | $7M | · | · | · | $-92M | · | · | |
| Levered FCF | · | · | · | · | · | $22M | · | · | · | $4M | · | · | · | $-96M | · | · |
الربحية 7
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -10.1% | -13.4% | · | -16.5% | -20.2% | -15.8% | · | -8.9% | -10.6% | -20.2% | · | -41.4% | -43.0% | -57.2% | · | -56.5% | |
| Net Margin | -8.9% | -12.2% | · | -14.8% | -18.5% | -13.3% | · | -7.2% | -9.1% | -18.4% | · | -40.6% | -42.4% | -56.6% | · | -57.7% | |
| Pretax Margin | -8.9% | -12.2% | · | -14.8% | -18.4% | -13.3% | · | -7.0% | -8.8% | -18.3% | · | -40.6% | -42.5% | -56.6% | · | -57.6% | |
| EBITDA Margin | -10.1% | -11.3% | · | -16.5% | -20.2% | -13.9% | · | -8.9% | -10.6% | -18.3% | · | -41.4% | -43.0% | -55.1% | · | -56.5% | |
| ROA | -3.0% | -3.9% | · | -5.1% | -6.2% | -4.2% | · | -2.1% | -2.7% | -4.9% | · | -8.9% | -9.6% | -11.1% | · | -10.5% | |
| ROE | -4.4% | -5.7% | · | -8.2% | -9.7% | -6.6% | · | -3.8% | -5.2% | -9.4% | · | -19.0% | -21.3% | -23.0% | · | -21.7% | |
| ROIC | -4.0% | -5.1% | · | -7.3% | -8.3% | -6.0% | · | -4.2% | -4.9% | -8.6% | · | -12.8% | -16.6% | -18.9% | · | -29.0% |
السيولة والملاءة 4
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 3.0 | · | 3.3 | 3.7 | 3.9 | · | 4.4 | 4.1 | 4.1 | · | 4.4 | 3.8 | 3.9 | · | 3.1 | |
| Quick Ratio | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 1.4 | 1.2 | · | 1.8 | 2.2 | 2.3 | · | 2.8 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Interest Coverage | · | · | · | -93.4 | -107.3 | -78.8 | · | -12.5 | -14.0 | -23.8 | · | -34.1 | -35.4 | -45.2 | · | -51.1 |
الكفاءة 2
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 2.1 | 1.9 | · | 2.0 | 1.7 | 1.7 | · | 1.6 | 1.4 | 1.4 | · | 1.1 | 1.1 | 1.2 | · | 1.2 |
التقييم (آخر 12 شهرًا) 13
| المقياس | اتجاه | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.59B | $2.34B | · | $2.08B | $1.90B | $1.72B | · | $1.49B | $1.31B | $1.14B | · | $982M | $912M | $845M | · | $761M | |
| Net Income TTM | $-341M | $-341M | · | $-287M | $-237M | $-204M | · | $-246M | $-325M | $-424M | · | $-478M | $-514M | $-542M | · | $-556M | |
| Market Cap | $38.98B | $28.55B | · | $22.14B | $23.10B | $19.22B | · | $15.76B | $13.36B | $11.18B | · | $5.27B | $5.55B | $6.29B | · | $4.26B | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.79B | |
| P/E | -110.8 | -80.6 | · | -75.2 | -93.9 | -87.3 | · | -61.3 | -39.0 | -24.7 | · | -10.1 | -9.8 | -10.2 | · | -7.5 | |
| P/S | 15.1 | 12.2 | · | 10.6 | 12.2 | 11.2 | · | 10.6 | 10.2 | 9.8 | · | 5.4 | 6.1 | 7.5 | · | 5.6 | |
| P/B | 21.4 | 16.1 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Tangible Book | 29.5 | 22.6 | · | 17.7 | 18.5 | 15.5 | · | 17.9 | 16.0 | 14.1 | · | 6.7 | 9.3 | 9.7 | · | 11.8 | |
| P / Cash Flow | · | 710.6 | · | · | · | 432.4 | · | · | · | 414.0 | · | · | · | -77.8 | · | · | |
| P / FCF | · | 1582.9 | · | · | · | 849.1 | · | · | · | 1672.1 | · | · | · | -68.0 | · | · | |
| EV / EBITDA | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -31.9 | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 5.0 | |
| Earnings Yield | -0.90% | -1.2% | · | -1.3% | -1.1% | -1.1% | · | -1.6% | -2.6% | -4.1% | · | -9.9% | -10.2% | -9.8% | · | -13.3% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الإيرادات | $2.31B | $1.70B | $1.08B | $820M | $625M |
| هامش الربح التشغيلي % | -13.4% | -13.1% | -41.2% | -66.0% | -74.9% |
| صافي الدخل | $-208M | $-190M | $-435M | $-548M | $-472M |
| EPS المخفف | $-1.52 | $-1.53 | $-3.78 | $-5.57 | $-5.21 |
الميزانية العمومية
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| الدين / حقوق الملكية | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| النسبة الحالية | 3.4 | 4.0 | 4.1 | 3.9 | 5.0 |
| النسبة السريعة | 0.7 | 1.0 | 1.7 | 3.7 | 4.7 |
التدفق النقدي
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $109M | $69M | $-286M | $-479M | $-376M |
آخر الأخبار أحدث العناوين التي تذكر هذه الشركة
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
📊
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 935 مقدمي إقرار · $20.5B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 165 (+55 مقابل الربع السابق) | 63 (-36 مقابل الربع السابق) | 347 (+42 مقابل الربع السابق) | 250 (-6 مقابل الربع السابق) | +14.8M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $1690649234 | 6228216 | 8,24% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1569697628 | 5782640 | 7,65% | الأسهم |
| FMR LLC | $1189034607 | 4380308 | 5,80% | الأسهم |
| STATE STREET CORP | $992317506 | 3655618 | 4,84% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $965965683 | 3558540 | 4,71% | الأسهم |
| Castle Hook Partners LP | $704759120 | 2596276 | 3,44% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $644934457 | 2382981 | 3,14% | الأسهم |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $602175451 | 2218366 | 2,94% | الأسهم |
| NORGES BANK | $496243717 | 1828122 | 2,42% | الأسهم |
| FRED ALGER MANAGEMENT, LLC | $467285974 | 1721444 | 2,28% | الأسهم |
| Sofinnova Investments, Inc. | $420823506 | 1550280 | 2,05% | الأسهم |
| Capital World Investors | $408365851 | 1504387 | 1,99% | الأسهم |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $408180994 | 1503706 | 1,99% | الأسهم |
| MAVERICK CAPITAL LTD | $368266171 | 1356663 | 1,80% | الأسهم |
| D. E. Shaw & Co., Inc. | $322096327 | 1186577 | 1,57% | الأسهم |
| GOLDMAN SACHS GROUP INC | $311099616 | 1146066 | 1,52% | الأسهم |
| Clearbridge Investments, LLC | $276424438 | 1018325 | 1,35% | الأسهم |
| RTW INVESTMENTS, LP | $271450000 | 1000000 | 1,32% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $249356413 | 918609 | 1,22% | الأسهم |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $197243187 | 726628 | 0,96% | الأسهم |
| ARK Investment Management LLC | $186989592 | 688855 | 0,91% | الأسهم |
| Sumitomo Mitsui Trust Group, Inc. | $174716892 | 643643 | 0,85% | الأسهم |
| Chevy Chase Trust Holdings, LLC | $162830912 | 599856 | 0,79% | الأسهم |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $160551817 | 591460 | 0,78% | الأسهم |
| FIRST TRUST ADVISORS LP | $138768953 | 511214 | 0,68% | الأسهم |
| GILDER GAGNON HOWE & CO LLC | $135199396 | 498064 | 0,66% | الأسهم |
| AMERICAN CENTURY COMPANIES INC | $129951802 | 478732 | 0,63% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $125949543 | 463988 | 0,61% | الأسهم |
| Avala Global LP | $124867000 | 460000 | 0,61% | الأسهم |
| JANE STREET GROUP, LLC | $120781406 | 444949 | 0,59% | الأسهم |
| Robeco Institutional Asset Management B.V. | $110918814 | 408616 | 0,54% | الأسهم |
| VIKING GLOBAL INVESTORS LP | $106053886 | 390694 | 0,52% | الأسهم |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | $105594050 | 389000 | 0,51% | الأسهم |
| Driehaus Capital Management LLC | $104202054 | 383872 | 0,51% | الأسهم |
| GOLDMAN SACHS GROUP INC | $103829625 | 382500 | 0,51% | عقد خيار الشراء |
| Swiss National Bank | $103096710 | 379800 | 0,50% | الأسهم |
| JANE STREET GROUP, LLC | $100300775 | 369500 | 0,49% | عقد خيار البيع |
| Amova Asset Management Americas, Inc. | $99926238 | 368066 | 0,49% | الأسهم |
| Man Group plc | $97455436 | 359018 | 0,48% | الأسهم |
| California Public Employees Retirement System | $93399430 | 344076 | 0,46% | الأسهم |
| Squarepoint Ops LLC | $91279949 | 336268 | 0,45% | الأسهم |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $84486098 | 311240 | 0,41% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $82819395 | 305100 | 0,40% | عقد خيار البيع |
| DIMENSIONAL FUND ADVISORS LP | $82812880 | 305076 | 0,40% | الأسهم |
| COATUE MANAGEMENT LLC | $80563646 | 296790 | 0,39% | الأسهم |
| Capital Impact Advisors, LLC | $80411091 | 296228 | 0,39% | الأسهم |
| AMERIPRISE FINANCIAL INC | $75314616 | 277451 | 0,37% | الأسهم |
| ENVESTNET ASSET MANAGEMENT INC | $74936546 | 276064 | 0,37% | الأسهم |
| CITADEL ADVISORS LLC | $72099020 | 265607 | 0,35% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $71251553 | 262485 | 0,35% | الأسهم |
| ORBIMED ADVISORS LLC | $71119900 | 262000 | 0,35% | الأسهم |
| TWO SIGMA ADVISERS, LP | $70490993 | 307700 | 0,34% | الأسهم |
| PRINCIPAL FINANCIAL GROUP INC | $70377484 | 259265 | 0,34% | الأسهم |
| PointState Capital LP | $70037357 | 258012 | 0,34% | الأسهم |
| Point72 Asset Management, L.P. | $68655134 | 252920 | 0,33% | الأسهم |
| Assenagon Asset Management S.A. | $68098390 | 250869 | 0,33% | الأسهم |
| BlackRock, Inc. | $61219847 | 225529 | 0,30% | الأسهم |
| National Pension Service | $61139769 | 225234 | 0,30% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $58410679 | 292068 | 0,28% | الأسهم |
| TD Asset Management Inc | $56207523 | 207064 | 0,27% | الأسهم |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | $55932001 | 206049 | 0,27% | الأسهم |
| CITADEL ADVISORS LLC | $54561450 | 201000 | 0,27% | عقد خيار البيع |
| Artemis Investment Management LLP | $54313616 | 200087 | 0,26% | الأسهم |
| NEUBERGER BERMAN GROUP LLC | $52978986 | 195170 | 0,26% | الأسهم |
| Mitsubishi UFJ Asset Management Co., Ltd. | $50424281 | 185759 | 0,25% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $49380284 | 181913 | 0,24% | الأسهم |
| Eversept Partners, LP | $47722810 | 175807 | 0,23% | الأسهم |
| Erste Asset Management GmbH | $47112625 | 173011 | 0,23% | الأسهم |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $47109261 | 173547 | 0,23% | الأسهم |
| RHUMBLINE ADVISERS | $46531361 | 171418 | 0,23% | الأسهم |
| JENNISON ASSOCIATES LLC | $46107586 | 169857 | 0,22% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $45830804 | 168837 | 0,22% | الأسهم |
| LPL Financial LLC | $45315137 | 166937 | 0,22% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $44300640 | 163200 | 0,22% | عقد خيار الشراء |
| Qube Research & Technologies Ltd | $43724895 | 161079 | 0,21% | الأسهم |
| IEQ CAPITAL, LLC | $40419133 | 148901 | 0,20% | الأسهم |
| Ensign Peak Advisors, Inc | $39971827 | 147253 | 0,19% | الأسهم |
| JANE STREET GROUP, LLC | $39930295 | 147100 | 0,19% | عقد خيار الشراء |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $39561022 | 197815 | 0,19% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $39068984 | 143927 | 0,19% | الأسهم |
| ROYAL BANK OF CANADA | $38963000 | 143535 | 0,19% | الأسهم |
| PANAGORA ASSET MANAGEMENT INC | $38891999 | 143275 | 0,19% | الأسهم |
| HighTower Advisors, LLC | $38255720 | 140931 | 0,19% | الأسهم |
| Caption Management, LLC | $38003000 | 140000 | 0,19% | عقد خيار الشراء |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $37658258 | 138730 | 0,18% | الأسهم |
| Rokos Capital Management LLP | $37210859 | 137049 | 0,18% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $36308609 | 133758 | 0,18% | الأسهم |
| RAYMOND JAMES FINANCIAL INC | $35775481 | 131794 | 0,17% | الأسهم |
| MAPLELANE CAPITAL, LLC | $34338425 | 126500 | 0,17% | عقد خيار الشراء |
| CANADA PENSION PLAN INVESTMENT BOARD | $33741235 | 124300 | 0,16% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $32343539 | 119151 | 0,16% | الأسهم |
| Davern Capital Partners, LP | $32295764 | 118975 | 0,16% | الأسهم |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $32267262 | 118870 | 0,16% | الأسهم |
| ThornTree Capital Partners LP | $31493900 | 116021 | 0,15% | الأسهم |
| CITADEL ADVISORS LLC | $30918155 | 113900 | 0,15% | عقد خيار الشراء |
| MARSHALL WACE, LLP | $30550069 | 112544 | 0,15% | الأسهم |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $30538398 | 112501 | 0,15% | الأسهم |
| UBS Group AG | $29990339 | 110482 | 0,15% | الأسهم |
| Science & Technology Partners, L.P. | $29826926 | 109880 | 0,15% | الأسهم |
| AVIVA PLC | $29381205 | 108238 | 0,14% | الأسهم |
المطلعون على الشركة 21 من المطلعين · مسؤولون 1 · مديرون 12
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Robert Alan Schueren | CHIEF OPERATING OFFICER | 27 يناير، 2023 A | 24091 | 0 | 0 | $0 |
| Rowan E Chapman | مدير | 15 يوليو، 2026 S | 4663 | 0 | 3 | $-1138859 |
| Eric H Rubin | مدير | 26 يونيو، 2026 A | 2204 | 0 | 0 | $0 |
| Monica Bertagnolli | مدير | 26 يونيو، 2026 A | 7020 | 0 | 0 | $0 |
| Gail Boxer Marcus | مدير | 26 يونيو، 2026 A | 7852 | 0 | 1 | $-651646 |
| Roy D. Baynes | مدير | 26 يونيو، 2026 A | 20158 | 0 | 0 | $0 |
| Thomas J. Lynch Jr. | مدير | 26 يونيو، 2026 A | 1905 | 0 | 0 | $0 |
| Herm Rosenman | مدير | 26 يونيو، 2026 A | 5927 | 0 | 5 | $-15143996 |
| ROELOF BOTHA ("RB") | مدير | 26 يونيو، 2026 A | 4585 | 0 | 6 | $-17184060 |
| Dr. James I. Healy | مدير | 25 إبريل، 2025 A | 46260 | 0 | 0 | $0 |
| Todd C Cozzens | مدير | 25 مايو، 2022 M | 15813 | 0 | 0 | $0 |
| John Steuart | مدير | 16 مايو، 2019 M | 7278 | 0 | 0 | $0 |
| Edward C. Driscoll Jr. | مدير | 16 مايو، 2019 M | 52009 | 0 | 0 | $0 |
| Jonathan Sheena | — | 10 أغسطس، 2026 S | 230464 | 0 | 41 | $-7235616 |
| Matthew Rabinowitz | — | 7 أغسطس، 2026 S | 2000 | 0 | 25 | $-23012521 |
| Michael Burkes Brophy | — | 4 أغسطس، 2026 S | 51637 | 0 | 7 | $-1498665 |
| John Fesko | — | 3 أغسطس، 2026 S | 183774 | 0 | 3 | $-519299 |
| Solomon Moshkevich | — | 3 أغسطس، 2026 S | 129019 | 0 | 16 | $-3185170 |
| Daniel Rabinowitz | — | 3 أغسطس، 2026 S | 170073 | 0 | 19 | $-13604463 |
| Steven Leonard Chapman | — | 3 أغسطس، 2026 S | 99897 | 0 | 13 | $-3322018 |
| Ruth Williams Brinkley | — | 24 إبريل، 2026 A | 5475 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
الناشطون والمالكون بنسبة 5%+ 1 حيازة
المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.
| مقدم | مقدم | حصة | الحالة | الغرض | إيداع |
|---|---|---|---|---|---|
| Sofinnova Venture Partners VIII, L.P. (“SVP VIII”), Sofinnova Management VIII, L.L.C., Sofinnova Venture Partners IX, L.P. (“SVP IX”), Sofinnova Management IX, L.L.C., Dr. Michael F. Powell (“Powell”), Dr. James I. Healy ×3 إيداعات | 13 فبراير، 2020 | — | إيداع أولي | استثمار سلبي | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 113 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| EKG · First Trust Exchange-Traded Fund II | 4,66% | 483 NS | 30 يونيو، 2026 | N-PORT |
| GNOM · Global X Funds | 4,15% | 10370 NS | 31 مايو، 2026 | N-PORT |
| ARKG · ARK ETF Trust | 4,07% | 243718 NS | 30 إبريل، 2026 | N-PORT |
| FBT · First Trust Exchange-Traded Fund | 3,79% | 393185 NS | 30 يونيو، 2026 | N-PORT |
| IBB · iShares Trust | 3,13% | 1021038 SH | 21 أغسطس، 2026 | يومي |
| WUGI · INVESTMENT MANAGERS SERIES TRUST II | 2,42% | 3222 NS | 30 يونيو، 2026 | N-PORT |
| MEDI · Harbor ETF Trust | 2,35% | 3142 NS | 30 إبريل، 2026 | N-PORT |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 2,28% | 83154 SH | 21 أغسطس، 2026 | يومي |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 2,17% | 5611 NS | 30 إبريل، 2026 | N-PORT |
| FFOX · FundX Investment Trust | 2,03% | 17937 NS | 30 يونيو، 2026 | N-PORT |
| MID · AMERICAN CENTURY ETF TRUST | 1,72% | 7656 NS | 31 مايو، 2026 | N-PORT |
| HFGO · Hartford Funds Exchange-Traded Trust | 1,57% | 13843 NS | 30 إبريل، 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,43% | 2615 NS | 31 مايو، 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,34% | 56770 NS | 30 إبريل، 2026 | N-PORT |
| IWP · iShares Trust | 1,25% | 787080 SH | 21 أغسطس، 2026 | يومي |
| ARKK · ARK ETF Trust | 1,17% | 369404 NS | 30 إبريل، 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 2954 NS | 30 إبريل، 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 1,01% | 1802288 SH | 19 أغسطس، 2026 | يومي |
| LABU · Direxion Shares ETF Trust | 0,98% | 24696 NS | 30 إبريل، 2026 | N-PORT |
| TAX · EA Series Trust | 0,92% | 1046 NS | 29 مايو، 2026 | N-PORT |
| TEXN · iShares Trust | 0,74% | 396 SH | 21 أغسطس، 2026 | يومي |
| IYH · iShares Trust | 0,69% | 81515 SH | 21 أغسطس، 2026 | يومي |
| HQGO · Lattice Strategies Trust | 0,68% | 1580 NS | 30 إبريل، 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,66% | 1989 NS | 31 مايو، 2026 | N-PORT |
| IMCG · iShares Trust | 0,60% | 75096 SH | 21 أغسطس، 2026 | يومي |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,56% | 54813 NS | 30 إبريل، 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,54% | 404713 SH | 19 أغسطس، 2026 | يومي |
| CANC · Tema ETF Trust | 0,54% | 4238 NS | 31 مايو، 2026 | N-PORT |
| CGMM · Capital Group Equity ETF Trust I | 0,48% | 60571 NS | 31 مايو، 2026 | N-PORT |
| FTC · First Trust Exchange-Traded AlphaDE… | 0,48% | 29486 NS | 30 إبريل، 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,44% | 1643356 SH | 19 أغسطس، 2026 | يومي |
| VB · VANGUARD INDEX FUNDS | 0,44% | 3120454 SH | 19 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,44% | 60581 NS | 30 إبريل، 2026 | N-PORT |
| LQAI · Exchange Listed Funds Trust | 0,40% | 41 NS | 30 إبريل، 2026 | N-PORT |
| CVMC · Morgan Stanley ETF Trust | 0,37% | 1390 NS | 30 يونيو، 2026 | N-PORT |
| IWR · iShares Trust | 0,32% | 555868 SH | 21 أغسطس، 2026 | يومي |
| IMCB · iShares Trust | 0,30% | 15799 SH | 21 أغسطس، 2026 | يومي |
| SIZE · iShares Trust | 0,30% | 4071 SH | 21 أغسطس، 2026 | يومي |
| EUSA · iShares, Inc. | 0,29% | 17533 SH | 21 أغسطس، 2026 | يومي |
| ROUS · Lattice Strategies Trust | 0,28% | 8068 NS | 30 إبريل، 2026 | N-PORT |
| GSLC · Goldman Sachs ETF Trust | 0,26% | 178926 NS | 31 مايو، 2026 | N-PORT |
| FTQI · First Trust Exchange-Traded Fund VI | 0,25% | 8600 NS | 30 يونيو، 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,25% | 21762 SH | 21 أغسطس، 2026 | يومي |
| MMLG · First Trust Exchange-Traded Fund VI… | 0,24% | 1020 NS | 31 مايو، 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,24% | 5580 NS | 30 إبريل، 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,24% | 558 NS | 31 مايو، 2026 | N-PORT |
| JMOM · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 23988 NS | 30 إبريل، 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,22% | 103 NS | 31 مايو، 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,22% | 2049 NS | 31 مايو، 2026 | N-PORT |
| GSEW · Goldman Sachs ETF Trust | 0,20% | 15978 NS | 31 مايو، 2026 | N-PORT |